| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS30058051 | HIV | ENSG00000151577.14 | protein_coding | DRD3 | No | No | 1814 | A1A4V4 E9PCM4 P35462 X5D2G4 |
| TVIS20057150 | HPV | ENSG00000151577.14 | protein_coding | DRD3 | No | No | 1814 | A1A4V4 E9PCM4 P35462 X5D2G4 |
| TVIS20057354 | HPV | ENSG00000151577.14 | protein_coding | DRD3 | No | No | 1814 | A1A4V4 E9PCM4 P35462 X5D2G4 |
| TVIS20040604 | HPV | ENSG00000151577.14 | protein_coding | DRD3 | No | No | 1814 | A1A4V4 E9PCM4 P35462 X5D2G4 |
| TVIS44006680 | HTLV-1 | ENSG00000151577.14 | protein_coding | DRD3 | No | No | 1814 | A1A4V4 E9PCM4 P35462 X5D2G4 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | DRD3 |
|---|---|
| DrugBank ID | DB06216 |
| Drug Name | Asenapine |
| Target ID | BE0000581 |
| UniProt ID | P35462 |
| Regulation Type | antagonist |
| PubMed IDs | 21655346; 21658377; 18308814 |
| Citations | Citrome L: Role of sublingual asenapine in treatment of schizophrenia. Neuropsychiatr Dis Treat. 2011;7:325-39. doi: 10.2147/NDT.S16077. Epub 2011 May 26.@@Tadori Y, Forbes RA, McQuade RD, Kikuchi T: Functional potencies of dopamine agonists and antagonists at human dopamine D(2) and D(3) receptors. Eur J Pharmacol. 2011 Sep;666(1-3):43-52. doi: 10.1016/j.ejphar.2011.05.050. Epub 2011 Jun 1.@@Shahid M, Walker GB, Zorn SH, Wong EH: Asenapine: a novel psychopharmacologic agent with a unique human receptor signature. J Psychopharmacol. 2009 Jan;23(1):65-73. doi: 10.1177/0269881107082944. Epub 2008 Feb 28. |
| Groups | Approved |
| Direct Classification | |
| SMILES | CN1CC2C(C1)C1=C(OC3=CC=C(Cl)C=C23)C=CC=C1 |
| Pathways | |
| PharmGKB | |
| ChEMBL | CHEMBL3187365 |
